Can a High-Tech care model help millions with diabetes?

NCT ID NCT06251323

Recruiting now Disease control Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large study tests a new way of managing type 2 diabetes in community health centers. The approach uses a team of providers and technology to personalize care. Researchers will compare blood sugar control in clinics that start the program at different times. The goal is to see if this model can reduce the number of patients with dangerously high blood sugar levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: iPATH implementation approach (team-based, technology-enabled care model)
What this could lead to: If successful, this could provide a scalable way for community health centers to better manage type 2 diabetes and reduce the number of patients with poorly controlled blood sugar.
What could go wrong: This is an implementation study, not a drug trial, so it tests a care model rather than a new treatment. Results may vary across clinics and may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

Board of Trustees of the Leland Stanford Junior University
RECRUITING

Stanford, California, 94305, United States
Impactivo, LLC.
RECRUITING

San Juan, Puerto Rico, 00907, Puerto Rico
President and Fellows of Harvard College, T.H. Chan School
RECRUITING

Boston, Massachusetts, 02115, United States
The Ohio State University
RECRUITING

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.